SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (466)12/23/1999 3:56:00 AM
From: GeoDude  Respond to of 1475
 
From my uneducated POV, I see the following positives: research in a good area, some competitive advantage, 2-3 years of cash at current burn rate (sufficient), well regarded by the SI bio-crowd, small market cap.

Negative: need appointment to trade. 7600 shares per day on average. Long time (3-5 years?) to wait for an approved and marketable product.

Overall: GREAT risk/reward for the patient investor. Little downside.

I will buy unless somebody tells me I missed something.

Season's Greetings.

LIA



To: scaram(o)uche who wrote (466)12/23/1999 4:51:00 PM
From: WTDEC  Read Replies (1) | Respond to of 1475
 
Rick,

Remember mid-day posts on VRTX?

>>I don't know if I buy that. [ * BTRN, BTRN, BTRN, BTRN, BTRN, BTRN * ]>>
Well, cap size makes a big delta here with VRTX closing in on $1B versus $50M. I see they are working on REGN now and that is sort of between the other two. I'm betting they will get to the micro-caps soon. Amazing market.. :)

Well they got there for a few thousand shares! What will happen with real volume?
<GGG>

Walter


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News